Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2024 was expected before 31 July 2025 and has not been filed.
Financials
Financial year 2023
RPO NucleoGenesis from Gent, company number BE0782980238, closed financial year 2023 with a result of € 2,885 after tax. For that financial year RPO NucleoGenesis recorded a gross margin of € 8,231 and equity of € 20,385. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2024.
€ 20,385
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2,885
Profit after tax over the fiscal year.
€ 96,962
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2023. Retained profit grew to € 2,885.
Debts at end 2023
None
No bank loans on the last day of the fiscal year.
€ 72,583
Supplier invoices still open on the last day of the fiscal year.
€ 1,354
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
What happened to RPO NucleoGenesis?
What happened at RPO NucleoGenesis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2023: profit of € 2,885. Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
Paid € 802 in corporate taxes since 2023.
Management
Behind RPO NucleoGenesis are Richard Baum, Andreas Türler, Coin Medical Clinical Research Consultancy and Nidac. Richard Baum is also behind RADIOMOLECULAR PRECISION ONCOLOGY.
Directors
According to the 2023 annual accounts
Andreas Türler
Director
Coin Medical Clinical Research Consultancy
Director · represented by Hugo Jansen
Director · represented by Andreas WALKENHORST
Establishments
Establishment units
Physical locations of this company
Bassebeekstraat 39
9031 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0782.980.238
- VAT number
- BE 0782.980.238
- Registered office
- Bassebeekstraat 39, 9031 Gent
- Names & denominations
- RPO NucleoGenesis
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 March 2022
- Peppol
- Active · Active since 24 Dec 2025
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Speur- en ontwikkelingswerk op biotechnologisch gebied
Activiteiten van holdings
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van medische beeldvorming en medische laboratoria
Overige dienstverlenende activiteiten op het gebied van informatie
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Holdings
+2